EMS-CHEMIE HOLDING Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of EMSN?
Owner TypeNumber of SharesOwnership Percentage
Institutions2,298,2819.83%
Individual Insiders2,363,00010.1%
General Public4,503,60419.3%
Private Companies14,224,14360.8%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 79.56% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
30.4%
Emesta Holding AG
7,112,072CHF 4.3b0%no data
30.4%
Mamira Holding AG
7,112,071CHF 4.3b0%no data
10.1%
Miriam Blocher
2,363,000CHF 1.4b0%no data
3.04%
UBS Asset Management AG
711,058CHF 430.5m0%0.04%
1.42%
BlackRock, Inc.
332,164CHF 201.1m3.55%no data
1.25%
The Vanguard Group, Inc.
291,753CHF 176.7m1%no data
0.63%
Norges Bank Investment Management
147,420CHF 89.3m0%0.01%
0.35%
Pictet Asset Management Limited
81,633CHF 49.4m0%0.04%
0.25%
J. Safra Sarasin Investmentfonds Ltd
59,000CHF 35.7m0%2.74%
0.23%
ZKB Asset Management
54,080CHF 32.7m0%0.07%
0.22%
Geode Capital Management, LLC
50,886CHF 30.8m0.11%no data
0.17%
Vontobel Asset Management AG
38,930CHF 23.6m0%0.14%
0.16%
Zürcher Kantonalbank, Investment Arm
37,740CHF 22.9m0%0.19%
0.14%
TD Asset Management, Inc.
33,875CHF 20.5m0%0.02%
0.1%
State Street Global Advisors, Inc.
23,529CHF 14.2m1.45%no data
0.095%
Charles Schwab Investment Management, Inc.
22,108CHF 13.4m-1.91%no data
0.093%
GAM Holding AG
21,736CHF 13.2m0%0.2%
0.092%
zCapital AG
21,500CHF 13.0m0%0.78%
0.066%
Deutsche Asset & Wealth Management
15,370CHF 9.3m0%no data
0.065%
Dimensional Fund Advisors LP
15,104CHF 9.1m0.27%no data
0.062%
Mirabaud Asset Management (Suisse) SA
14,600CHF 8.8m0%1.7%
0.06%
Pax Asset Management AG
14,000CHF 8.5m0%0.86%
0.05%
Goldman Sachs Asset Management, L.P.
11,615CHF 7.0m-1.68%no data
0.048%
Amundi Asset Management SAS
11,231CHF 6.8m-0.05%no data
0.047%
Mirabaud Asset Management (Europe) S.A.
10,990CHF 6.7m0%1.92%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/06/10 09:30
End of Day Share Price 2025/06/06 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

EMS-CHEMIE HOLDING AG is covered by 17 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Konstantin WiechertBaader Helvea Equity Research
Volker BosseBaader Helvea Equity Research
Aron CeccarelliBerenberg